HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
azaftig
a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice
Networked:
3
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Polysaccharides: 15383
Proteoglycans: 4798
azaftig: 3
Glycoconjugates: 1353
Glycoproteins: 24834
Proteoglycans: 4798
azaftig: 3
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Glycoproteins: 24834
Proteoglycans: 4798
azaftig: 3
Experts
1.
Figueroa, Julio E
: 1 article (05/2002)
2.
Prasad, Chandan
: 1 article (05/2002)
3.
Vijayagopal, Parakat
: 1 article (05/2002)
Related Diseases
1.
Weight Loss (Weight Reduction)
05/03/2002 - "
So far, very little is known about the mechanism underlying loss of fat depot in mice or weight loss in patients excreting azaftig.
"
05/03/2002 - "
Administration of azaftig to mice results in weight loss that is associated with loss of fat depot.
"
01/27/1999 - "
The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8).
"
01/27/1999 - "
We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects.
"
01/27/1999 - "
We have isolated and partially characterized a proteoglycan (named azaftig) from the urine of a cancer patient experiencing weight loss.
"
2.
Neoplasms (Cancer)
01/27/1999 - "
The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8).
"
01/27/1999 - "
We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects.
"
01/27/1999 - "
We have isolated and partially characterized a proteoglycan (named azaftig) from the urine of a cancer patient experiencing weight loss.
"
01/01/1999 - "
Azaftig, a urinary proteoglycan from a cachectic cancer patient, causes profound weight loss in mice.
"
05/03/2002 - "
Azaftig is an urinary proteoglycan present in some cancer and AIDS patients experiencing weight loss.
"
3.
Acquired Immunodeficiency Syndrome (AIDS)
01/27/1999 - "
The azaftig-like immunoreactivity was present in 69.2% (9/13) of patients with weight loss, but only in 27.0% (3/11) of weight-stable cancer or AIDS patients and none of the control subjects (n = 8).
"
01/27/1999 - "
We report the presence of azaftig in the urine of cancer and AIDS patients experiencing weight loss, but not in the control or weight-stable subjects.
"
05/03/2002 - "
Azaftig is an urinary proteoglycan present in some cancer and AIDS patients experiencing weight loss.
"
01/01/1999 - "
We have isolated and partially characterized a proteoglycan (azaftig) from the urine of cancer and AIDS patients experiencing weight loss.
"
4.
Body Weight (Weight, Body)
01/01/1999 - "
When given to mice, the purified azaftig resulted in a significant decrease in body weight and body fat without any effect on appetite.
"
Related Drugs and Biologics
1.
Proteoglycans (Proteoglycan)